The Food and Drug Administration Friday authorized for emergency use the first commercial test kit to detect monkeypox in lesion swab specimens. Only laboratories certified under the Clinical Laboratory Improvement Amendments to perform moderate or high complexity tests are authorized to perform the Abbott Molecular test. 
 
In other news, the FDA approved the first vaccine to administer to mothers during pregnancy to prevent whooping cough (pertussis) in infants under two months old. The Boostrix vaccine previously was approved to protect pregnant women, adults and children age 10 and older. 

Related News Articles

Headline
States, territories, health facilities and tribal organizations can apply through March 27 for up to $525,000 million each for residential treatment programs…
Blog
According to the CDC, 80% of pregnancy-related deaths can be prevented; that’s a 20% increase from previous years. Know why? That’s actually the theme for…
Headline
In recognition of today’s Maternal Health Awareness Day, Aisha Syeda, senior program manager for AHA’s work on maternal health, highlights strategies health…
Headline
Only 16% of pregnant people who reported drinking alcohol in 2017 or 2019 were advised by a health care provider to stop or reduce their alcohol use, although…
Headline
Emergency departments in the highest quartile of pediatric readiness based on National Pediatric Readiness Project standards have lower death rates for…
Headline
States that expanded Medicaid coverage to low-income adults in 2014 under the Affordable Care Act reduced postpartum hospitalizations for low-income people,…